Home › Markets › Health Care › BOLD

Boundless Bio Inc. (BOLD)

BOLD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.43
-4.71% on the day
Market cap
$56.2M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerBOLD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2024
SEC CIK0001782303
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2026-08-31
Latest annual report10-K2026-03-09
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-08-28
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 153 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TLPHTalphera Inc.$1.07-0.93%$55.5M
CNTBConnect Biopharma Holdings Limited$0.9188+1.45%$57.9M
ALDXAldeyra Therapeutics Inc.$0.8998-0.66%$54.3M
GOSSGossamer Bio Inc.$9.76+5.17%$59.7M
TENXTenax Therapeutics Inc.$1.60-12.57%$59.9M
PLRXPliant Therapeutics Inc.$0.9680-1.83%$59.9M
XLOXilio Therapeutics Inc.$9.22+1.60%$60.7M
RNXTRenovoRx Inc.$1.15-8.00%$51.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier